XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
OPERATING ACTIVITIES              
Net income $ 152,471 $ 135,302 $ 126,251 $ 92,904 $ 287,773 $ 219,155  
Adjustments to reconcile net income to net cash (used for) provided by operating activities:              
Depreciation and amortization 24,866   25,054   50,508 48,932  
Provision for credit losses         6,605 4,298  
Stock-based compensation         44,028 42,245  
Deferred income taxes         15,419 (13,392)  
Excess tax benefit on stock-based compensation         (8,155) (2,274)  
Change in loss on disposal group         (569) 0  
Other operating activities         7,254 10,841  
Changes in operating elements:              
Receivables         (108,002) (290,042)  
Contract assets         11,595 (70,514)  
Prepaid expenses and other         (27,934) 8,034  
Increase (Decrease) in Right of Use Asset         24,704 (3,093)  
Accounts payable and outstanding checks         121,249 122,404  
Accrued compensation         (64,607) (13,276)  
Accrued transportation expense         (5,056) 63,389  
Accrued income taxes         30,866 (60)  
Other accrued liabilities         (20,779) 1,108  
Increase (Decrease) in Operating Lease Liability         (31,844) 3,248  
Other assets and liabilities         604 2,096  
Net cash provided by operating activities         333,659 133,099  
INVESTING ACTIVITIES              
Purchases of property and equipment         (10,640) (15,238)  
Purchases and development of software         (25,601) (26,573)  
Proceeds from divestiture         27,737 0  
Net cash used for investing activities         (8,504) (41,811)  
FINANCING ACTIVITIES              
Proceeds from stock issued for employee benefit plans         27,026 19,026  
Stock tendered for payment of withholding taxes         (54,589) (19,808)  
Repurchase of common stock         (128,767) 0  
Cash dividends         (152,355) (147,283)  
Proceeds from short-term borrowings         1,240,800 1,653,000  
Payments on short-term borrowings         (1,264,800) (1,625,000)  
Net cash used for financing activities         (332,685) (120,065)  
Effect of exchange rates on cash and cash equivalents         6,985 (3,581)  
Net change in cash and cash equivalents, including cash and cash equivalents classified within assets held for sale         (545) (32,358)  
Plus: net decrease in cash and cash equivalents within assets held for sale 10,776   0   10,776 0  
Cash and cash equivalents, beginning of period   $ 145,762   $ 145,524 145,762 145,524 $ 145,524
Cash and cash equivalents, end of period $ 155,993   $ 113,166   $ 155,993 $ 113,166 $ 145,762